Proline-rich tyrosine kinase 2 and its phosphorylated form pY881 are novel prognostic markers for non-small-cell lung cancer progression and patients' overall survival.
about
FAK in cancer: mechanistic findings and clinical applicationsPyk2 promotes tumor progression in multiple myelomaALDH maintains the stemness of lung adenoma stem cells by suppressing the Notch/CDK2/CCNE pathway.BMI-1, a promising therapeutic target for human cancer.Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancerClinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.Expression of microRNA-452 via adenoviral vector inhibits non-small cell lung cancer cells proliferation and metastasis.Triptolide Inhibits Lung Cancer Cell Migration, Invasion, and Metastasis.Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer.Pyk2 promotes tumor progression in renal cell carcinoma
P2860
Q27026533-F0F6DEBB-1427-4EB1-B275-4C8A4BD3B5A6Q34398382-66FBCC3A-F697-40EB-8D53-BB1E7CD73599Q35132170-805A89ED-4CFC-4676-B12B-07D3AF287E95Q35870390-FB738728-7809-421F-8A1C-CBCEBD25C7BDQ36057092-92B93260-65F0-47C1-942F-4C851B2D5BEDQ38792018-55FC8361-F204-49B8-8C0B-76F11E762094Q38807885-A8D13B6A-0D77-4390-BC3A-F9FA49EBD0F5Q43192162-81EB00BD-E462-4406-BED4-348F64F93F25Q54111596-0E9EDFDB-DDA3-4902-A18A-4D97BB641BBDQ57788719-A601D408-6CD9-4A56-8567-345559663FE3
P2860
Proline-rich tyrosine kinase 2 and its phosphorylated form pY881 are novel prognostic markers for non-small-cell lung cancer progression and patients' overall survival.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proline-rich tyrosine kinase 2 ...... nd patients' overall survival.
@en
Proline-rich tyrosine kinase 2 ...... nd patients' overall survival.
@nl
type
label
Proline-rich tyrosine kinase 2 ...... nd patients' overall survival.
@en
Proline-rich tyrosine kinase 2 ...... nd patients' overall survival.
@nl
prefLabel
Proline-rich tyrosine kinase 2 ...... nd patients' overall survival.
@en
Proline-rich tyrosine kinase 2 ...... nd patients' overall survival.
@nl
P2093
P2860
P356
P1476
Proline-rich tyrosine kinase 2 ...... nd patients' overall survival.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2013.439
P407
P577
2013-08-06T00:00:00Z